Prime Minister Narendra Modi’s call to “buy and make swadeshi” reflects more than nostalgia. With US tariffs now in effect, the government is nudging Indians to rethink consumption, not through the protectionist walls of the past, but through a modern “buycott.” The idea is simple: channel the strength of India’s vast consumer market to support local producers, absorb export capacity, and soften the blow of shrinking foreign demand. India lacks China’s muscle to enforce economic boycotts abroad, but it does have a powerful domestic lever: household consumption, which has steadily contributed nearly half of GDP growth. Add falling GST rates, the prospect of cheaper loans, and a public that places high trust in business and government, and the conditions are ripe. This latest swadeshi push is less about nostalgia and more about resilience, a strategic effort to turn tariff shocks into a pathway toward self-reliance. Market Watch📈 Markets end with slim gains! Indian equities surged intraday on Monday, but gains were capped as investors followed a sell-on-rise strategy amid lingering tariff concerns and foreign portfolio outflows.
Cautious mood kept gains in check despite early momentum. ⚖️📊 Get a headstart on tomorrow’s print edition:India’s IT sector finds a fresh wave of optimism in weaker rupee and AI bets Adani Power’s pivot to hydro signals a strategically positive shift GST cut may revive hotel stocks. Should investors check in now? SC allows Cognizant to use hexagonal logo in India until final ruling Premium readsThe wild west of crypto taxes: Your ITR needs a guiding hand Why IRCTC does not have much competition Ceat's Camso acquisition faces earnings, integration hurdles before payoff How Fed rate cuts affect your portfolio, and how to benefit from them Sneak a PeekLong Story, a much-loved Mint feature, is published every weekday. Before the next piece hits the stands, here’s your exclusive glimpse into what’s brewing on our desk. Catch the story in the morning edition. Superbugs are rising. India’s scientists are fighting backBig Pharma is vacating infectious diseases research to chase more lucrative segments like oncology and diabetes. This has left behind a gaping void. A set of Indian companies are diving in—Wockhardt, Orchid Pharma, and Bugworks. A successful antibiotic drug can change their fortunes. Today in HistoryQueen Elizabeth II, the UK’s longest-reigning monarch, died at Balmoral Castle in Scotland after 70 years on the throne. Her passing marked the end of a historic era, and her son, Charles, Prince of Wales, succeeded her as King Charles III, ushering in a new reign. Love a Mint story? Here's how to support it.Do you have a favourite writer at Mint? Every day, we strive to publish stories that need to be told, and your digital subscription makes all the difference. It tells us we’re on the right track and helps us continue delivering the in-depth journalism you rely on. If you’re not yet a subscriber, now’s the perfect time to join! Starting today, many of our staff writers are sharing special, personalized discount coupon codes. So if there's a Mint writer whose work you admire, reach out to them on social media or via email and ask for their unique coupon code! (And if you're already a subscriber, a quick note telling them you appreciate their work would still make their day!) Note: The coupon codes are available only with in-house writers, and not our external columnists. If your request for a code fails, please write to me at shravani.sinha@livemint.com. Thanks for reading! Edited by Rashmi Sanyal. Produced by Shad Hasnain.
|
सोमवार, 8 सितंबर 2025
0 टिप्पणियाँ: